Journal article
A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
- Abstract:
-
Tafenoquine is a promising new 8-aminoquinoline drug that may be useful for malaria prophylaxis in nonpregnant persons with normal glucose-6-phosphate dehydrogenase (G6PD) function. A randomized, double-blind, placebo-controlled chemoprophylaxis trial was conducted with adult residents of northern Ghana to determine the minimum effective weekly dose of tafenoquine for the prevention of infection by Plasmodium falciparum. The primary end point was a positive malaria blood smear result during t...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
- Volume:
- 36
- Issue:
- 5
- Pages:
- 541-549
- Publication date:
- 2003-03-01
- DOI:
- EISSN:
-
1537-6591
- ISSN:
-
1058-4838
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:81802
- UUID:
-
uuid:6da1d4b7-6d3f-49ba-83b6-db101c9addc1
- Local pid:
- pubs:81802
- Source identifiers:
-
81802
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2003
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record